CLINICAL_TRIALS
trial_result
· 2014-11-20
Clinical Trial Update: Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma [Phase 2]
Summary
A Phase 2 trial evaluating vinblastine in pediatric patients with recurrent or refractory low-grade glioma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Hospital for Sick Children | Conditions: Glioma | Phase 2 | Status: COMPLETED